PHILADELPHIA, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ: ACHC) on behalf of purchasers of ACADIA securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period"). Investors that suffered losses from ACADIA (NASDAQ: ACHC) investments can follow the link below for more information regarding the lawsuit: CLICK HERE to learn mor ...

NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company's senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

Core Viewpoint - Acadia Healthcare Company is facing a class-action lawsuit from investors alleging misleading business practices, violating the Securities Exchange Act of 1934 [1][2]. Group 1: Allegations and Lawsuit Details - The lawsuit, filed in the Middle District of Tennessee, claims that Acadia made false or misleading statements about its operations from February 28, 2020, to October 18, 2024 [2]. - Specific allegations include that Acadia's business model involved holding patients against their will without medical necessity, subjecting patients to abuse, and deceiving insurance providers by billing for unnecessary patient stays [2]. - The lawsuit references a New York Times article published on September 1, 2024, which exposed Acadia's practices and led to a stock price drop of over 4% [3]. Group 2: Regulatory Scrutiny and Stock Impact - On September 27, 2024, Acadia disclosed receiving a subpoena from the U.S. District Court for the Western District of Missouri and a request for information from the U.S. Attorney's Office for the Southern District of New York, related to admissions practices and billing [4]. - This disclosure reportedly caused Acadia's stock price to plummet by more than 16% [4]. Group 3: Investigation and Whistleblower Information - Hagens Berman, a shareholder rights firm, is investigating the claims against Acadia, emphasizing the potential harm to both patients and investors [5]. - The firm encourages individuals with non-public information regarding Acadia to consider whistleblower options, which may offer rewards up to 30% of any successful recovery made by the SEC [5].

RADNOR, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Middle District of Tennessee against Acadia Healthcare Company, Inc. ("Acadia Healthcare") (NASDAQ: ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period") The lead p ...

NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare" or the "Company") (NASDAQ: ACHC) in the United States District Court Middle District of Tennessee on behalf of all persons and entities who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and September 26, 2024, both dates inclusive ...

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all investors and entities that purchased or otherwise acquired Acadia Healthcare Company (NASDAQ: ACHC) securities between February 28, 2020 and September 26, 2024. Acadia is a leading provider of behavioral healthcare services across the United States. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is ...

Shares of Acadia Healthcare Company, Inc. (ACHC) lost 18.7% since it reported third-quarter 2024 earnings on Oct. 30, despite an earnings beat in the third quarter. Investors might be worried about the reduced revenue and EBITDA outlook for 2024 due to the sale of two subscale satellite programs. However, the third-quarter earnings benefited from improved volumes and higher patient days. ACHC reported adjusted third-quarter earnings of 91 cents per share, which beat the Zacks Consensus Estimate by 1.1%. The ...

NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company's senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

Lawsuit Overview - Leading securities law firm Bleichmar Fonti & Auld LLP has filed a lawsuit against Acadia Healthcare Company, Inc and certain senior executives [1] - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Acadia Healthcare's securities [2] - Investors have until December 16, 2024 to ask the Court to be appointed to lead the case [2] Allegations Against Acadia Healthcare - Acadia Healthcare is accused of misrepresenting its financial results, which were allegedly driven by insurance fraud and holding vulnerable people against their will in its facilities, even when not medically necessary [3] - The New York Times investigation found that Acadia has lured patients into its facilities and held them against their will, even when detaining them was not medically necessary [4] - The Veterans Affairs Department is investigating whether Acadia is defrauding government health insurance programs by holding patients longer than is medically necessary [6] Impact on Stock Price - Following the New York Times article on September 1, 2024, Acadia's stock price fell $3 72 per share, or 4 5%, to close at $78 21 per share on September 3, 2024 [4] - On September 27, 2024, Acadia disclosed receiving requests for information from the U S Attorney's Office and a grand jury subpoena, causing a 16% decline in stock price from $75 66 to $63 28 per share [5] - The New York Times article on October 18, 2024, about the Veterans Affairs Department investigation caused a 12% decline in Acadia's stock price from $59 32 to $52 03 per share [6] Legal Actions and Investigations - Acadia received a request for information from the U S Attorney's Office for the Southern District of New York and a grand jury subpoena from the U S District Court for the Western District of Missouri [5] - The company expects similar requests from the U S Securities and Exchange Commission related to its patient admissions, length of stay, and billing practices [5] - Several former Acadia employees in Georgia and Missouri have been interviewed by agents from the F B I and the inspector general's office of the Health and Human Services Department [6]